Red Tree Venture Capital has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Engrail Therapeutics's $157M Series B+ round in March 2024, alongside Ysios Capital, RiverVest, Pivotal Life Sciences and 6 others. That company is in Health and bio.

What Red Tree Venture Capital invests in

• Health and bio · 1 · 100%

How Red Tree Venture Capital invests

Share is of the 1 round on Recent Funding that name Red Tree Venture Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Red Tree Venture Capital portfolio companies

• EEngrail Therapeutics$157MSeries B+ · Mar 2024

Most frequent co-investors

• FF-Prime Capital1 shared round · last Mar 19, 2024
• NNorwest Venture Partners1 shared round · last Mar 19, 2024
• EEight Roads Ventures1 shared round · last Mar 19, 2024
• FForesite Capital1 shared round · last Mar 19, 2024
• YYsios Capital1 shared round · last Mar 19, 2024
• RRiverVest1 shared round · last Mar 19, 2024
• FForbion Capital Partners1 shared round · last Mar 19, 2024
• PPivotal Life Sciences1 shared round · last Mar 19, 2024
• LLongwood Fund1 shared round · last Mar 19, 2024

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Red Tree Venture Capital, which is a subset of its real portfolio. API: /api/v1/investors/red-tree-venture-capital (get a free API key). More: the most active VC firms and new venture capital funds.